Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm of Head of Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Not applicableStudy completedNCT01321450
What this trial is testing

Economisation of Whipple Resection Using an Ultrasonic Dissection Device

Who this might be right for
Resectable Pancreatic Head NeoplasmResectable Periampullary NeoplasmChronic Pancreatitis
Universitätsklinikum Hamburg-Eppendorf 82
Not applicableUnknownNCT06438705
What this trial is testing

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Who this might be right for
Head and Neck TumorLung CancerPancreatic Cancer
Nanjing First Hospital, Nanjing Medical University 20
Early research (Phase 1)Study completedNCT04121286
What this trial is testing

JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Allist Pharmaceuticals, Inc. 17
Not applicableLooking for participantsNCT07232810
What this trial is testing

Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer

Who this might be right for
Pancreatic Head CancerPancreatic Ductal Adenocarcinoma
Minia University 90
Not applicableStudy completedNCT05131815
What this trial is testing

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerCancer MetastaticNeoplasms+19 more
Cedars-Sinai Medical Center 8
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Not applicableStudy completedNCT05697198
What this trial is testing

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

Who this might be right for
Lung CancerOvarian CancerUterine Cancer+10 more
Labcorp Corporation of America Holdings, Inc 1,429
Very early researchNot Yet RecruitingNCT07639970
What this trial is testing

Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors

Who this might be right for
Breast CancerHead and Neck Cancer (H&N)Pancreatic Cancer+1 more
Hua Pang 20
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Ended earlyNCT02605083
What this trial is testing

A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
Effector Therapeutics 66
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)UnknownNCT05830097
What this trial is testing

Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer, BreastCancer, LungCancer of Pancreas+2 more
Coherent Biopharma (Hefei) Co., Ltd. 260
Not applicableUnknownNCT01698190
What this trial is testing

Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions

Who this might be right for
Pancreatic TumorGastric TumorEsophageal Tumor+2 more
Stony Brook University 400
Early research (Phase 1)Study completedNCT00703638
What this trial is testing

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 16
Not applicableLooking for participantsNCT07035587
What this trial is testing

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Who this might be right for
Lung NeoplasmsPancreatic NeoplasmsColorectal Neoplasms+5 more
Yonsei University 1,200
Not applicableStudy completedNCT02374255
What this trial is testing

Improving Goals of Care Discussion in Advanced Cancer Patients

Who this might be right for
Primary Stage IV HepatobiliaryEsophagealColorectal Cancer+9 more
Icahn School of Medicine at Mount Sinai 265
Early research (Phase 1)Ended earlyNCT04152018
What this trial is testing

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Cancer+8 more
Pfizer 85
Next Page